Combination PD-1 and PD-L1 inhibitors for kidney cancer are no more beneficial than PD-1 inhibitor alone By Sharon Kell|2019-11-20T10:02:53+00:0020 Nov 2019|Drug treatments| A recent phase II clinical trial has shown that combined [...] Read More Comments Off on Combination PD-1 and PD-L1 inhibitors for kidney cancer are no more beneficial than PD-1 inhibitor alone